Anteris Technologies (Nasdaq:AVR) today announced one-year clinical outcomes for its DurAVR transcatheter heart valve (THV).

The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the ...

Most clinical research for transcatheter aortic valve replacement in patients with severe aortic stenosis has been performed in patients with tricuspid aortic valves. However, many patients who ...

The results underscore the need to perform CT imaging when deciding between procedures in patients with aortic stenosis.

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Transcatheter aortic valve replacement in failing transcatheter valves may not be feasible in ...

In our center, most transarterial TAVI procedures are performed under local anesthetic, sedation and fluoroscopic rather than echocardiographic guidance. The heart valve team consists of two ...

Patients with bicuspid and tricuspid aortic stenosis at high or intermediate risk for surgery undergoing TAVR with the latest-generation Sapien 3 (Edwards Lifesciences) valve have similar rates of all ...

SAN FRANCISCO -- Long-term outcomes after transcatheter aortic valve replacement (TAVR) were looking more and more like those ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- ...